tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Aptose Biosciences Advances Tuspetinib in AML Treatment with Promising Trial Results
PremiumCompany AnnouncementsAptose Biosciences Advances Tuspetinib in AML Treatment with Promising Trial Results
26d ago
Aptose Biosciences Advances TUSCANY Trial with Dose Escalation
Premium
Company Announcements
Aptose Biosciences Advances TUSCANY Trial with Dose Escalation
1M ago
Aptose Biosciences Appoints Ernst & Young as New Auditor
Premium
Company Announcements
Aptose Biosciences Appoints Ernst & Young as New Auditor
1M ago
Aptose Biosciences Secures $8.5M Loan for AML Therapy
PremiumCompany AnnouncementsAptose Biosciences Secures $8.5M Loan for AML Therapy
3M ago
Aptose Biosciences Secures Cash Advance Amid Financial Uncertainty
Premium
Company Announcements
Aptose Biosciences Secures Cash Advance Amid Financial Uncertainty
3M ago
Aptose Biosciences Reports Promising Results from TUSCANY Trial in AML
Premium
Company Announcements
Aptose Biosciences Reports Promising Results from TUSCANY Trial in AML
3M ago
Aptose Biosciences Reports Promising AML Trial Results and Expands Market Presence
PremiumCompany AnnouncementsAptose Biosciences Reports Promising AML Trial Results and Expands Market Presence
4M ago
Aptose Biosciences Reports Promising Results from TUSCANY Trial for AML Treatment
Premium
Company Announcements
Aptose Biosciences Reports Promising Results from TUSCANY Trial for AML Treatment
4M ago
Aptose Biosciences Auditor KPMG Not Re-Appointed
Premium
Company Announcements
Aptose Biosciences Auditor KPMG Not Re-Appointed
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100